Trials / Completed
CompletedNCT01641120
Assessing Tolerability of Avonex Intramuscular Injections
Assessing Tolerability of Avonex Intramuscular Injections With a 25 Gauge Needle Versus 30 Gauge Needle
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Trinity Health Of New England · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate patients' views when injecting Avonex intramuscularly.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Avonex | Intramuscular injection administered using 25 gauge or 30 gauge needle |
Timeline
- Start date
- 2012-05-01
- Primary completion
- 2014-02-01
- Completion
- 2014-02-01
- First posted
- 2012-07-16
- Last updated
- 2016-02-01
- Results posted
- 2016-02-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01641120. Inclusion in this directory is not an endorsement.